Surrozen (SRZN) Other Non Operating Income (2021 - 2026)
Surrozen (SRZN) recorded quarterly Other Non Operating Income of -$41.1 million in Q1 2026, up 31.02% quarter-over-quarter from -$59.6 million in Q4 2025, and down 208.22% on a YoY basis from $38.0 million in Q1 2025.
Surrozen (SRZN) Other Non Operating Income (2021 - 2026) Analysis & Trends
Surrozen's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$41.1 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 208.22% year-over-year to -$41.1 million; the TTM figure through Mar 2026 stood at -$105.4 million (down 662.18% YoY), while the FY2025 annual figure was -$26.3 million, down 36.18% from the prior year.
- Other Non Operating Income was -$41.1 million for Q1 2026 at Surrozen, up from -$59.6 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $38.0 million in Q1 2025 to a low of -$59.6 million in Q4 2025.
- Historically, Other Non Operating Income has averaged -$4.6 million across 5 years, with a median of $83000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income jumped 92100.0% in 2022, then sank 6667.55% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $920000.0 in 2022, then slumped by 67.17% to $302000.0 in 2023, then tumbled by 6667.55% to -$19.8 million in 2024, then sank by 200.46% to -$59.6 million in 2025, then soared by 31.02% to -$41.1 million in 2026.
- The last three Other Non Operating Income figures came in at -$41.1 million (Q1 2026), -$59.6 million (Q4 2025), and -$20.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.11 Mn |
| Dec 31, 2025 | -59.59 Mn |
| Sep 30, 2025 | -20.92 Mn |
| Jun 30, 2025 | 16.22 Mn |
| Mar 31, 2025 | 37.99 Mn |
| Dec 31, 2024 | -19.83 Mn |
| Sep 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | -85,000.00 |
| Dec 31, 2023 | 302,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | -252,000.00 |
| Dec 31, 2022 | 920,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | 6.50 Mn |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -328,000.00 |